These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17170606)

  • 1. The role of nitric oxide in erectile dysfunction: implications for medical therapy.
    Burnett AL
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12 Suppl 4):53-62. PubMed ID: 17170606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and penile erectile function.
    Toda N; Ayajiki K; Okamura T
    Pharmacol Ther; 2005 May; 106(2):233-66. PubMed ID: 15866322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
    Ghalayini IF
    Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.
    Hallén K; Wiklund NP; Gustafsson LE
    Br J Pharmacol; 2007 Feb; 150(3):353-60. PubMed ID: 17179943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat.
    de Tejada IS
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S40-2. PubMed ID: 15224136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cyclic GMP Export by Multidrug Resistance Protein 4: A New Strategy to Treat Erectile Dysfunction?
    Boydens C; Pauwels B; Vanden Daele L; Van de Voorde J
    J Sex Med; 2017 Apr; 14(4):502-509. PubMed ID: 28258955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
    Francis SH; Corbin JD
    Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
    Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
    Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications.
    Nehra A; Colreavy F; Khandheria BK; Chandrasekaran K
    World J Urol; 2001 Feb; 19(1):40-5. PubMed ID: 11289569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide signaling in cavernous smooth muscle.
    Lin CS; Lin G; Lue TF
    J Sex Med; 2005 Jul; 2(4):478-91. PubMed ID: 16422842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channels and erectile dysfunction.
    Archer SL
    Vascul Pharmacol; 2002 Jan; 38(1):61-71. PubMed ID: 12378824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide regulation of penile erection: biology and therapeutic implications.
    Burnett AL
    J Androl; 2002; 23(5):S20-6. PubMed ID: 12236169
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
    Rosen RC; Kostis JB
    Am J Cardiol; 2003 Nov; 92(9A):9M-18M. PubMed ID: 14609619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of the effects of sildenafil (VIAGRA).
    Glossmann H; Petrischor G; Bartsch G
    Exp Gerontol; 1999 Jun; 34(3):305-18. PubMed ID: 10433386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission.
    Rajfer J; Aronson WJ; Bush PA; Dorey FJ; Ignarro LJ
    N Engl J Med; 1992 Jan; 326(2):90-4. PubMed ID: 1309211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.
    Pickard R
    Eur Urol; 2007 Jul; 52(1):259-60. PubMed ID: 17616089
    [No Abstract]   [Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.
    Li WJ; Peng Y; Zhou J; Li B; Wang H; Zhang J; Wang Z
    J Sex Med; 2012 May; 9(5):1319-27. PubMed ID: 22429732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.